The Technical Analyst
Select Language :
Amicus Therapeutics Inc [FOLD]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Amicus Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Amicus Therapeutics Inc is listed at the  Exchange

-0.67% $11.78

America/New_York / 28 mar 2024 @ 16:00


Amicus Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 3 479.61 mill
EPS: -0.510
P/E: -23.10
Earnings Date: May 08, 2024
SharesOutstanding: 295.38 mill
Avg Daily Volume: 3.14 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -23.10 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-3.93x
Company: PE -23.10 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 11.23 - 12.33

( +/- 4.67%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Campbell Bradley L Sell 13 375 Common Stock
2024-01-09 Campbell Bradley L Buy 28 810 Common Stock
2024-01-09 Campbell Bradley L Sell 23 577 Common Stock
2024-01-09 Crowley John F Buy 57 620 Common Stock
2024-01-09 Crowley John F Sell 36 865 Common Stock
INSIDER POWER
19.21
Last 100 transactions
Buy: 1 805 018 | Sell: 1 194 686

Forecast: 16:00 - $11.75

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $11.75
Forecast 2: 16:00 - $11.75
Forecast 3: 16:00 - $11.75
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $11.78 (-0.67% )
Volume 2.40 mill
Avg. Vol. 3.14 mill
% of Avg. Vol 76.48 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Amicus Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Amicus Therapeutics Inc

RSI

Intraday RSI14 chart for Amicus Therapeutics Inc

Last 10 Buy & Sell Signals For FOLD

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$13.31N/AActive
Profile picture for
            Amicus Therapeutics Inc

FOLD

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Last 10 Buy Signals

Date Signal @
OSMOUSDMar 29 - 08:451.380
BELUSDMar 29 - 08:440.982
DPIUSDMar 29 - 08:44$145.76
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12
DCRUSDMar 29 - 08:30$28.20
RBNUSDMar 29 - 08:301.670
GTUSDMar 29 - 08:30$9.91
BORAUSDMar 29 - 08:29$0.227

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.